{
  "docId": "019de071-368f-770d-b306-cadfb30d59b4",
  "docSlug": "a64b1d8ea419e9037d657543bdbf6776",
  "documentTitle": "Alkermes | Results Presentation Deck | 13 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 13,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "other",
  "function": "establish_context",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "Product introduction slide for Alkermes.",
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de071-368f-770d-b306-cadfb30d59b4/9",
  "deckHref": "/decks/019de071-368f-770d-b306-cadfb30d59b4",
  "deckJsonHref": "/decks/019de071-368f-770d-b306-cadfb30d59b4.json",
  "deckAnchorHref": "/decks/019de071-368f-770d-b306-cadfb30d59b4#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.05,
        "y": 0.88
      },
      "kind": "disclaimer",
      "text": "Full prescribing information, including boxed warning, for LYBALVI® may be found at www.lybalvi.com/lybalvi-prescribing-information.pdf",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "378f6c4a-f666-459e-928e-1bde553e6b98",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.4,
        "x": 0.55,
        "y": 0.35
      },
      "kind": "image",
      "text": "Four bottles of LYBALVI in different dosages",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "656b43cc-c1b5-415a-904a-37229bee5c0c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.45,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "list",
      "text": "Once-daily, oral atypical antipsychotic composed of olanzapine, an established antipsychotic agent, and samidorphan, a new chemical entity. Approved for the treatment of adults with schizophrenia and bipolar I disorder. Less weight gain than olanzapine. Launch Q4'21.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0adbe7f6-98c6-4df5-83ef-74cf6e1a6d38",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "LYBALVI®: Anticipated New Revenue Stream in Oral Atypical Antipsychotic Market",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e9a6aef0-3112-4a69-b82e-c06a02fac898",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "9019298c-f398-48d6-9d1f-c33f2d21405e",
      "evidence": "list/bullet: Once-daily, oral atypical antipsychotic composed of olanzapine, an established antipsychotic agent, and samidorphan, a new chemical entity.",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 9,
      "from": 5,
      "beatId": "5a49c208-4998-40da-a540-5e62d48cb538",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "KPI Overview",
      "beatSlug": null,
      "evidence": "The presentation dives deeper into specific KPIs and performance metrics",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 5,
      "name": "Voice Of Customer",
      "slug": "51-voice-of-customer",
      "bestFor": "Product strategy, customer experience, market research",
      "matchId": "ec6447f9-faef-4169-9da3-2db163a6f69a",
      "evidence": "The presentation provides an overview of VIVITROL and ARISTADA performance",
      "position": 0,
      "objective": "to demonstrate commercial performance",
      "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response",
      "confidence": 0.6,
      "description": "Let customer quotes and feedback drive the narrative and validate the insight"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}